2026 ANNUAL GENERAL MEETING
SEPTEMBER 22, 2026 | 7:00PM
The College of Pharmacy of Newfoundland and Labrador is pleased to present this year’s Annual General Meeting (AGM) online. The AGM is open to all registered pharmacy professionals, so if you would like to join us, RSVP by registering online:
Register Now for the CPNL 2026 Annual General Meeting & Q&A
agenda
- Land Acknowledgement
- Call to Order and Adoption of Agenda
- Introduction of Board Members
- Minute of Silence in Memoriam
- Highlights of the 2025 Annual Report
- Appointment of Auditor for 2027
- Board Member Election Results
- Recognition of Outgoing Board Members
- Inauguration of Incoming Chair
- Recognition of Outgoing Chair
- Adjournment
A 20-30-minute question-and-answer period will be held, with virtual and in-person attendance options, immediately following the AGM, with an end time of 8:00 pm. This time is allotted for the board to engage with registered pharmacy professionals, key partners, and members of the public and address any questions they might have.
The 2025 Annual Report is available to view online at:
Effective Collaboration Between Pharmacy Professionals and 811 Healthline
Effective collaboration between pharmacy professionals and other health professionals is always in the best interests of patients. Ensuring that patients receive accurate information and have a clear understanding of service expectations can help reduce frustration for patients and healthcare professionals, and support timely access to appropriate care.
Recently, a pharmacist contacted CPNL about a concern where, at times, staff at 811 HealthLine (“811”) had referred patients to pharmacists for treatment of symptoms not currently within a pharmacist’s prescribing scope of practice (e.g., ear infections, sinus infections, strep throat). CPNL staff discussed this issue with leadership at Fonemed, the company responsible for 811, and they are committed to ensuring that their staff are notified of the concern and are directed towards accurate resources related to a pharmacist’s prescribing scope in this province.
In addition, Fonemed staff asked CPNL to share a message with pharmacy professionals regarding prescription renewal expectations, on their behalf. In situations where a pharmacist determines that extending a prescription is outside their scope or competency and refers the patient to 811, patients should be advised that prescription renewals through 811 is an appointment-based service and that requests may not be assessed immediately. Setting this expectation for patients and sharing that wait times may vary can help patients make informed decisions about their care options and avoid unnecessary frustration. Although wait times can vary, Fonemed indicated that the current wait for prescription renewal appointments is approximately two weeks.
Drug Scheduling Status of New Epinephrine Nasal Spray
CPNL has recently received questions from pharmacy professionals regarding a new epinephrine nasal spray for emergency use, Neffy. This product is not currently included in the National Drug Schedules and is categorized by Health Canada as an “Ethical” product. This means that while it does not legally require a prescription under federal legislation, there is still an intention that it is used or administered under the supervision of a health professional.
As such, the manufacturers of Neffy have submitted a request for the product to be reviewed by the National Drug Scheduling Advisory Committee (NDSAC) and have requested that it be considered for inclusion in Schedule 2. This request will be considered at the September 2026 meeting of NDSAC and the results of the decision will be posted to the Drug Schedules page of the CPNL website and included in a future issue of The PostScript.
In the meantime, pharmacists-in-charge should ensure that the product is sold only following consultation with a pharmacist.
Does your pharmacy have a continuous quality improvement (cqi) Coordinator?
Continuous Quality Improvement (CQI) and Medication Incident Reporting (MIR) are essential to safe pharmacy practice. In accordance with the CPNL’s Standards of Practice for CQI and MIR, and the requirements of MedSTEP NL, Pharmacists-in-Charge (PICs) are responsible for ensuring these processes are implemented and maintained within their pharmacy.
To support these efforts, PICs are encouraged to designate a pharmacist or pharmacy technician to serve as a CQI Coordinator. While the PIC remains accountable for CQI and MIR activities, a dedicated coordinator can help strengthen quality improvement initiatives and foster a culture of medication safety within the pharmacy.
A CQI Coordinator can help coordinate and advance medication safety and quality improvement initiatives in many ways, including:
Designate a CQI coordinator to champion quality improvement efforts and support CQI and MIR becoming an integral part of your daily practice!
Share Your Feedback with ISMP Canada: NIDR SMART Medication Safety Agenda
In June 2026, ISMP Canada shared the launch of the SMART (Specific, Measurable, Attainable, Relevant and Time-based) Medication Safety Agenda. Learning from incident reports submitted by community pharmacy teams to the National Incident Data Repository (NIDR) supports system improvements for patient safety. This new resource is a direct result of that shared work.
NIDR SMART Medication Safety Agenda: EN | FR
As part of ISMP Canada’s commitment to continuous improvement, they are now inviting feedback on the usefulness and relevance of this resource.
Please complete the following two-minute survey:
https://www.surveymonkey.com/r/668FYLM
Your input directly shapes how ISMP Canada develops and distributes future medication safety agendas.
Apply for NAPRA’s National Drug Scheduling Advisory Committee
The National Drug Scheduling Advisory Committee (NDSAC) is a committee of the National Association of Pharmacy Regulatory Authorities (NAPRA) which serves to advise NAPRA on matters relating to the National Drug Schedules (NDS) program.
NAPRA will have two (2) vacancies on the NDSAC arising in 2027 and is inviting applications for the following positions:
For complete details of the position and candidate requirements, visit: https://www.napra.ca/invitation-for-applications-for-napras-national-drug-scheduling-advisory-committee-7/
Individuals who meet the criteria and are interested in serving on the NDSAC must forward completed applications, resumes/CVs, and letters of recommendation to ndsac@napra.ca by no later than September 8, 2026.
Regular Reminders
Questions About Application of Standards of Practice
Questions regarding the application of CPNL Standards of Practice to pharmacy practice can be emailed to inforx@cpnl.ca. Your practice inquiry will be reviewed and directed to the appropriate staff member. Please allow 2-3 business days for a response.
Scheduling Appointments with Staff
CPNL staff are here to assist and support you. If you wish to meet with a staff member in person, please call to schedule an appointment before visiting our office. Having details regarding your inquiry will help us appropriately prioritize and prepare to answer your question if we need to collect additional information before calling you back or meeting with you. If you are unable to reach the staff person by phone, please leave a detailed message. Voicemails are regularly checked, and staff members get email alerts when a message is left on their phone line.
Keeping Contact Information Up to Date
Registered pharmacy professionals are responsible for ensuring that the contact information on their registrant profile, including email address and practice site, is accurate at all times. CPNL primarily uses email communication to send newsletters, renewal reminders, practice site assessment information, professional development audit information, calls for interest for committees, and other alerts. If the email address on file is incorrect, important information may be missed and/or disclosed to the wrong person. If your contact information changes, please update your information on file by logging into the Registrant Portal.